Impact of timing of antibiotic use on clinical outcomes in patients with urothelial cancer treated with immune checkpoint inhibitors (ICIs).

被引：0
|
作者：
Weinstock, Chana
Bandaru, Pradeep
Fernandes, Laura L.
Chang, Elaine
Girvin, Andrew
Tang, Shenghui
Agrawal, Sundeep
Suzman, Daniel L.
Singh, Harpreet
Brave, Michael Holman
Xu, James
Goldberg, Kirsten B.
Ibrahim, Amna
Theoret, Marc Robert
Pazdur, Richard
Beaver, Julia A.
机构：
[1] US FDA, Silver Spring, MD USA
[2] Palantir Technol, Washington, DC USA
[3] Palantir Technol, Menlo Pk, CA USA
[4] Medstar Washington Hosp Ctr, Washington, DC USA
[5] Johns Hopkins Univ, Baltimore, MD USA
[6] US FDA, Washington, DC USA
[7] NCI, NIH, Bethesda, MD 20892 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5045
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The impact of antibiotic use on clinical features and survival outcomes of cancer patients treated with immune checkpoint inhibitors
    Zhou, Jiaxin
    Huang, Guowei
    Wong, Wan-Ching
    Hu, Da-hai
    Zhu, Jie-wen
    Li, Ruiman
    Zhou, Hong
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [2] Association of biomarkers and outcomes in patients (pts) with metastatic urothelial carcinoma (mUC) treated with immune checkpoint inhibitors (ICIs).
    Reyes, Kevin R.
    Zhang, Li
    Zhu, Xiaolin
    Jindal, Tanya
    Deshmukh, Prianka
    de Kouchkovsky, Ivan
    Kumar, Vipul
    Maldonado, Edward
    Kwon, Daniel H.
    Chan, Emily
    Porten, Sima P.
    Borno, Hala
    Bose, Rohit
    Desai, Arpita
    Aggarwal, Rahul Raj
    Small, Eric Jay
    Fong, Lawrence
    Chou, Jonathan
    Friedlander, Terence W.
    Koshkin, Vadim S.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [3] Organ dysfunction (dys) and clinical outcomes in patients (pts) treated with immune checkpoint inhibitors (ICIs).
    Liu, Qi
    Sharon, Elad
    Zineh, Issam
    Xie, Diqiong
    Baxi, Shrujal S.
    Liu, Chao
    Zhi, Jizu
    Torres, Aracelis Z.
    Gossai, Anala
    Sridhara, Rajeshwari
    Booth, Brian
    Blumenthal, Gideon Michael
    Huang, Shiew-Mei
    Khozin, Sean
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [4] A systematic review and meta-analysis evaluating the impact of antibiotic use on the clinical outcomes of cancer patients treated with immune checkpoint inhibitors
    Crespin, Athena
    Le Bescop, Clement
    de Gunzburg, Jean
    Vitry, Fabien
    Zalcman, Gerard
    Cervesi, Julie
    Bandinelli, Pierre-Alain
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [5] Systematic review and meta-analysis evaluating the impact of antibiotic use on the clinical outcomes of patients with cancer treated with immune checkpoint inhibitors
    Zalcman, Gerard
    Crespin, Athena
    Cervesi, Julie
    Le Bescop, Clement
    Buffet, Renaud
    De Gunzburg, Jean
    Vitry, Fabien
    Bandinelli, Pierre-Alain
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [6] Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors
    Sanda, Gregory E.
    Shabto, Julie M.
    Goyal, Subir
    Liu, Yuan
    Martini, Dylan J.
    Nazha, Bassel
    Brown, Jacqueline T.
    Yantorni, Lauren B.
    Russler, Greta Anne
    Caulfield, Sarah
    Joshi, Shreyas S.
    Narayan, Vikram M.
    Kissick, Haydn
    Ogan, Kenneth
    Master, Viraj A.
    Carthon, Bradley C.
    Kucuk, Omer
    Bilen, Mehmet Asim
    ONCOLOGIST, 2023, : 1072 - 1078
  • [7] Impact of probiotics use on clinical outcomes of immune checkpoint inhibitors therapy in cancer patients
    Wan, Luying
    Wu, Chunlan
    Wu, Qin
    Luo, Shuimei
    Liu, Junjin
    Xie, Xianhe
    CANCER MEDICINE, 2023, 12 (02): : 1841 - 1849
  • [8] Effect of antibiotic use on outcomes in patients with Hodgkin lymphoma treated with immune checkpoint inhibitors
    Hwang, Steven R.
    Higgins, Alexandra
    Castillo Almeida, Natalia E.
    LaPlant, Betsy
    Maurer, Matthew J.
    Ansell, Stephen M.
    Witzig, Thomas E.
    Thanarajasingam, Gita
    Bennani, N. Nora
    LEUKEMIA & LYMPHOMA, 2021, 62 (01) : 247 - 251
  • [9] The association between antibiotic use and outcomes of HCC patients treated with immune checkpoint inhibitors
    Zhang, Lilong
    Chen, Chen
    Chai, Dongqi
    Li, Chunlei
    Guan, Yongjun
    Liu, Li
    Kuang, Tianrui
    Deng, Wenhong
    Wang, Weixing
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [10] Thyroid Dysfunction in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors (ICIs): Outcomes in a Multiethnic Urban Cohort
    D'Aiello, Angelica
    Lin, Juan
    Gucalp, Rasim
    Tabatabaie, Vafa
    Cheng, Haiying
    Bloomgarden, Noah A.
    Tomer, Yaron
    Halmos, Balazs
    CANCERS, 2021, 13 (06)
12345